Improved Tumor Response in Patients on Metformin Undergoing Yttrium-90 Radioembolization Segmentectomy for Hepatocellular Carcinoma
ConclusionMetformin may be associated with increased tumor response after Y-90 RS in patients with HCC.Level of EvidenceIII, Retrospective Study.
Source: CardioVascular and Interventional Radiology - Category: Radiology Source Type: research
More News: Cancer & Oncology | Carcinoma | Cardiology | Cardiovascular | Chemotherapy | Children | Diabetes | Endocrinology | Fortamet | Heart | Hepatocellular Carcinoma | Liver Cancer | Metformin | Radiology | Study